Gustave Roussy Cancer Campus

Paris 94805

1 studies enrolling now · 3 studies all time

What they study most

Advanced Melanoma, Cholangiocarcinoma, FGFR2 Amplification, FGFR2 Gene Activation, FGFR2 Gene Fusion/Rearrangement, FGFR2 Gene Mutation, FGFR2 Gene Translocation, Intrahepatic Cholangiocarcinoma, Other Solid Tumors, Adult

Studies at this site

• A Study of Lirafugratinib in Non-CCA Solid Tumors With FGFR2 Fusion or Rearrangement — Recruiting now
• REFOCUS: A First-in-Human Study of Highly Selective FGFR2 Inhibitor, RLY-4008, in Patients With ICC and Other Advanced Solid Tumors — Completed
• Intratumoral Injection of LTX-315 in Combination With Pembrolizumab in Advanced Melanoma — Completed